Yiyi Zhan

Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway

Chun-Li Da, Yuting Liu, Yiyi Zhan et al. · Oncology Reports · 2016 · 82 citations · Full text

<p>Knockdown of Long Non-Coding RNA HOTAIR Suppresses Cisplatin Resistance, Cell Proliferation, Migration and Invasion of DDP-Resistant NSCLC Cells by Targeting <em>miR-149-5p/Doublecortin-Like Kinase 1</em> Axis</p>

Yiyi Zhan, Xiuli Wang, Yanli Shen et al. · Cancer Management and Research · 2020 · 25 citations · Full text

An oral second-generation proteasome inhibitor oprozomib significantly inhibits lung cancer in a p53 independent manner <italic>in vitro</italic>

Hongge Zhu, Tianhai Wang, Xin Zhou et al. · Acta Biochimica et Biophysica Sinica · 2019 · 12 citations

Pathology, Inhibits Lung Cancer, P53 Independent Manner +17

PI3K inhibition sensitizes EGFR wild‑type NSCLC cell lines to erlotinib chemotherapy

Xin Zhou, Xiaowen Wang, Hongge Zhu et al. · Experimental and Therapeutic Medicine · 2020 · 12 citations · Full text

Oncology, Medicine, Receptor Tyrosine Kinase +14

Glycogen phosphorylase B promotes cell proliferation and migration through PI3K/AKT pathway in non-small cell lung cancer.

Yiyi Zhan, Ru Chen, Tianhai Wang et al. · PubMed · 2021 · 11 citations